Real-world evidence with a retrospective cohort of 15,968 Andalusian COVID-19 hospitalized patients suggests 21 new effective treatments and one drug that increases death risk

Carlos Loucera, Rosario Carmona, Marina Esteban-Medina, Gerrit Bostelmann, Dolores Muñoyerro-Muñiz, Román Villegas, María Peña-Chilet, Joaquin Dopazo
doi: https://doi.org/10.1101/2022.08.14.22278751

Article usage

Article usage: August 2022 to July 2025

AbstractFullPdf
Aug 2022110317215
Sep 2022245334
Oct 2022135031
Nov 2022104110
Dec 202278224
Jan 202352419
Feb 202348329
Mar 20234807
Apr 202343328
May 202325113
Jun 20232357
Jul 202331112
Aug 2023271114
Sep 202342816
Oct 202321319
Nov 20232119
Dec 2023803
Jan 20241214
Feb 20241219
Mar 20241946
Apr 20241646
May 20241828
Jun 20241606
Jul 202411711
Aug 202424411
Sep 20241625
Oct 202417715
Nov 20241616
Dec 20241006
Jan 202514218
Feb 202516244
Mar 2025522314
Apr 20251559
May 2025291316
Jun 2025261321
Jul 202518104
Back to top
Posted August 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Real-world evidence with a retrospective cohort of 15,968 Andalusian COVID-19 hospitalized patients suggests 21 new effective treatments and one drug that increases death risk
Carlos Loucera, Rosario Carmona, Marina Esteban-Medina, Gerrit Bostelmann, Dolores Muñoyerro-Muñiz, Román Villegas, María Peña-Chilet, Joaquin Dopazo
medRxiv 2022.08.14.22278751; doi: https://doi.org/10.1101/2022.08.14.22278751
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area